A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Center for Infectious Disease Research · Infectious Disease Research Institute · +12 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
814
total citations
- FWCI
- 71.27
- Percentile
- 100%
- References
- 43
Citations per year
Authors
33- DEDaniel E. Zak
Center for Infectious Disease Research, Infectious Disease Research Institute
- APAdam Penn‐Nicholson
University of Cape Town, South African Tuberculosis Vaccine Initiative
- TJThomas J. Scriba
University of Cape Town, South African Tuberculosis Vaccine Initiative
- ETEthan Thompson
Center for Infectious Disease Research, Infectious Disease Research Institute
- SSSara Suliman
University of Cape Town, South African Tuberculosis Vaccine Initiative
Topics & keywords
Topics
Keywords
- Medicine
- Prospective cohort study
- Tuberculosis
- Cohort study
- Cohort
- Disease
- Virology
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CCCarnegie Corporation of New York
- BABill and Melinda Gates FoundationAwards: 37772, OPP1023483, OPP1021972, 37885
- CUColumbia University
- AGAeras Global Tuberculosis Vaccine Foundation
- ECEuropean Commission
- SASouth African Medical Research Council
- CLClaude Leon Foundation
- DODepartment of Science and Technology, Republic of South Africa
- NINational Institutes of HealthAward: RO1-AI087915
- SFSeventh Framework ProgrammeAwards: 115308, 643381, 280873
- FIFogarty International CenterAward: 5 D43 TW000231